According to the ETF Finder at ETF Channel, NKTR makes up 4.01% of the First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) which is relatively unchanged on the day Friday.
In afternoon trading Friday, NKTR was down about 1.5% on the day.
Huge profits could be on the doorstep for these hot breakout setups.
The Oracle of Omaha believes in the future of U.S. business, says Jim Cramer. Plus, Buffett can admit his mistakes and we can learn from that.
Jim Cramer is bullish on Nektar Therapeutics and Alkermes, as well as Verizon and Bank of America.
Jim Cramer says what's more noteworthy than the pullback is the day's strong rebound.